In patients with congenital combined pituitary hormone deficiency (CCPHD), the function of the hypothalamus–pituitary–testis axis can be restored with pulsatile gonadotropin-releasing hormone (GnRH) ...
MedPage Today on MSN
Two Types of ADT for Prostate Cancer, Different Effects on Coronary Artery Plaque
Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...
One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.
ADT with leuprolide was tied to increased coronary plaque vs relugolix in prostate cancer. What does this mean for CV risk?
NEW ORLEANS -- Off-label use of oral elagolix (Orilissa) may be a more patient-friendly alternative to standard-of-care injectable GnRH antagonists for ovulation suppression during in vitro ...
Two Sealed Airtight Medical Vials Against Bright Background Front View. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations.
Use of a gonadotropin-releasing hormone antagonist is associated with lower risks for death than GnRH agonists, a systematic review and meta-analysis found. Use of degarelix, a gonadotropin-releasing ...
Credit: Getty Images. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations. Although a recent meta-analysis suggested that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results